These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35721790)

  • 1. Launching a CDMO in Brazil aiming to develop biopharmaceuticals for clinical trials.
    Ferreira RS; Morales MM; Barretti P; Barraviera B
    J Venom Anim Toxins Incl Trop Dis; 2022; 28():e20220017. PubMed ID: 35721790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDMOs Play a Critical Role in the Biopharmaceutical Ecosystem.
    Kurata H; Ishino T; Ohshima Y; Yohda M
    Front Bioeng Biotechnol; 2022; 10():841420. PubMed ID: 35387299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digitalization in pharmaceutical industry: What to focus on under the digital implementation process?
    Hole G; Hole AS; McFalone-Shaw I
    Int J Pharm X; 2021 Dec; 3():100095. PubMed ID: 34712948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contract development and manufacturing organization selection: critical considerations that can make or break your cell and gene therapy development.
    Pasdar MA; Sivilotti MM; Jaehn PS; Baghbaderani BA; Lee J; Levine BL; Milligan WD
    Cytotherapy; 2024 Jul; 26(7):656-659. PubMed ID: 38530691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equipment and Analytical Companies Meeting Continuous Challenges May 20-21 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-831. PubMed ID: 28756844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid and disposable facilities for manufacturing of biopharmaceuticals: pros and cons.
    Ravisé A; Cameau E; De Abreu G; Pralong A
    Adv Biochem Eng Biotechnol; 2009; 115():185-219. PubMed ID: 19623478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good management practices of venomous snakes in captivity to produce biological venom-based medicines: achieving replicability and contributing to pharmaceutical industry.
    Santos L; Oliveira C; Vasconcelos BM; Vilela D; Melo L; Ambrósio L; da Silva A; Murback L; Kurissio J; Cavalcante J; Cassaro CV; Barros L; Barraviera B; Ferreira RS
    J Toxicol Environ Health B Crit Rev; 2021 Jan; 24(1):30-50. PubMed ID: 33308037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Apilic Antivenom to Treat Massive, Africanized Honeybee Attacks: A Preclinical Study from the Lethality to Some Biochemical and Pharmacological Activities Neutralization.
    Teixeira-Cruz JM; Strauch MA; Monteiro-Machado M; Tavares-Henriques MS; de Moraes JA; Ribeiro da Cunha LE; Ferreira RS; Barraviera B; Quintas LEM; Melo PA
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33466223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia.
    Lu ML; Wu YX; Chen CH; Kuo PT; Chen YH; Lin CH; Wu TH
    PLoS One; 2016; 11(2):e0148539. PubMed ID: 26849777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple uses of fibrin sealant for nervous system treatment following injury and disease.
    Biscola NP; Cartarozzi LP; Ulian-Benitez S; Barbizan R; Castro MV; Spejo AB; Ferreira RS; Barraviera B; Oliveira ALR
    J Venom Anim Toxins Incl Trop Dis; 2017; 23():13. PubMed ID: 28293254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. License Compliance Issues For Biopharmaceuticals: Special Challenges For Negotiations Between Companies And Non-Profit Research Institutions.
    Ponzio TA; Feindt H; Ferguson S
    LES Nouv; 2011 Sep; 46(3):216-225. PubMed ID: 22162900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of manufacturing practices on quality of pharmaceutical products manufactured in Kenya.
    Orwa JA; Keter LK; Ouko SP; Kibwage IO; Rukunga GM
    East Afr Med J; 2004 Jun; 81(6):287-92. PubMed ID: 16167675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Launching the dialogue: Safety and innovation as partners for success in advanced manufacturing.
    Geraci CL; Tinkle SS; Brenner SA; Hodson LL; Pomeroy-Carter CA; Neu-Baker N
    J Occup Environ Hyg; 2018 Jun; 15(6):D45-D50. PubMed ID: 29580184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell roadmap - The industrial point of view.
    Elzaabi M; Thevenin A; Lirsac PN
    Biomed Mater Eng; 2017; 28(s1):S9-S13. PubMed ID: 28372274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A success in Toxinology translational research in Brazil: bridging the gap.
    Ferreira AS; Barraviera B; Barraviera SR; Abbade LP; Caramori CA; Ferreira RS
    Toxicon; 2013 Jul; 69():50-4. PubMed ID: 23333650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.